Prevalence of Dementia of Alzheimer Type and Apolipoprotein E Phenotypes in Aged Patients with Down's Syndrome
Overview
Affiliations
We investigated the exact prevalence of dementia of Alzheimer type (DAT) and apolipoprotein E (ApoE) phenotypes in 106 Japanese Down's syndrome (DS) patients. Among these patients 16 were diagnosed as having DAT. The prevalence of DAT was 0% in the 30- to 39-year-old group, 16% in the 40- to 49-year-old group, and 38% in those over 50 years old. The frequency of the epsilon4 allele in DS patients with DAT was 18.8%, which was considerably higher than that of nondemented DS patients (4.5%) and Japanese nondemented controls (6.7%). Especially, the frequency of the epsilon4 allele in DS patients who developed DAT under 50 years was significantly higher (28.6%). DS patients certainly develop DAT at earlier ages but the prevalence of DAT in each group of patients was lower than previously recognized. It is very likely that the ApoE epsilon4 is a risk factor for DAT even in DS patients with a genetic predisposition to Alzheimer's disease.
Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome.
Iulita M, Garzon Chavez D, Christensen M, Tamayo N, Plana-Ripoll O, Rasmussen S JAMA Netw Open. 2022; 5(5):e2212910.
PMID: 35604690 PMC: 9127560. DOI: 10.1001/jamanetworkopen.2022.12910.
Castro P, Zaman S, Holland A J Neurol. 2016; 264(4):804-813.
PMID: 27778163 PMC: 5374178. DOI: 10.1007/s00415-016-8308-8.
Nizetic D, Chen C, Hong W, Koo E Front Behav Neurosci. 2015; 9:299.
PMID: 26648852 PMC: 4664698. DOI: 10.3389/fnbeh.2015.00299.
Stem and progenitor cell dysfunction in human trisomies.
Liu B, Filippi S, Roy A, Roberts I EMBO Rep. 2014; 16(1):44-62.
PMID: 25520324 PMC: 4304728. DOI: 10.15252/embr.201439583.
Rivastigmine for dementia in people with Down syndrome.
Mohan M, Bennett C, Carpenter P Cochrane Database Syst Rev. 2009; (1):CD007658.
PMID: 19160344 PMC: 7197503. DOI: 10.1002/14651858.CD007658.